The French drugmaker on Monday announced progress on a deal to sell 50% of its subsidiary Opella to Clayton Dubilier & Rice, ...

Earlier this month Sanofi revealed talks were ongoing with CD&R, and has now confirmed the negotiations could result in the ...

A persistent, often progressive, lung disease, COPD results from chronic inflammation that leads to structural changes ...

Healthcare decision-makers are facing significant challenges that will intensify in the coming years as they work to address ...

French drama over sovereign paracetamol is really about a deeper ailment: underinvestment.

The CDC investigates potential bird flu infections in Washington farm workers. Baxter seeks to restore dialysis patient ...

By deploying relatable imagery of princesses pooping, Dulcolax has set out to challenge societal norms that teach girls to be ashamed of bodily functions.

The organisation sought the help of the home affairs adviser and law enforcement agencies in the ongoing struggle ...

Under the proposed deal, the PE firm would take a controlling 50% stake in Sanofi’s Opella unit, with state-owned Bpifrance taking a minority 2% position.

Sanofi will sell a 50% controlling stake in consumer healthcare unit Opella to private equity firm CD&R, with the French ...

Sanofi is now in “exclusive negotiations” with U.S. private equity firm Clayton, Dubilier & Rice (CD&R) to sell a 50% ...